Clinical Trial Update: PRC-063 in Adolescent ADHD [Phase 3]

View source ↗

Summary

Phase 3 clinical trial PRC-063 in adolescents with ADHD has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• PRC-063 (PRC-063)

Snippet

Sponsor: Rhodes Pharmaceuticals, L.P. | Conditions: ADHD | Phase 3 | Status: COMPLETED